Publications by authors named "Weining Volinn"

Claim this Profile
S
Strategy for Assessing New Drug Value in Orphan Diseases: An International Case Match Control Analysis of the PROPEL Study.
Owen A O'Connor, Enrica Marchi, Weining Volinn, Jin Shi, Thomas Mehrling

JNCI Cancer Spectr· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies.
Marc C Gittelman, Leonard S Marks, Lawrence A Hill, Weining Volinn, Gary Hoel

Open Access J Urol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
Steven A Kaplan, Claus G Roehrborn, Lawrence A Hill, Weining Volinn

Open Access J Urol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid efficacy of the highly selective α(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.
Leonard S Marks, Marc C Gittelman, Lawrence A Hill, Weining Volinn, Gary Hoel

J Urol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
West China hospital set of measures in Chinese to evaluate back pain treatment.
Ernest Volinn, Bangxiang Yang, Jing He, Xiaoming Sheng, Jian Ying, Weining Volinn

Pain Med· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men.
Scott A MacDiarmid, Lawrence A Hill, Weining Volinn, Gary Hoel

Urology· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.
Leonard S Marks, Marc C Gittelman, Lawrence A Hill, Weining Volinn, Gary Hoel

Urology· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity.
Patrick C Cartwright, Douglas E Coplen, Barry A Kogan, Weining Volinn, Eileen Finan

J Urol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.
Leonard S Marks, Marc C Gittelman, Lawrence A Hill, Weining Volinn, Gary Hoel

J Urol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Back pain claim rates in Japan and the United States: framing the puzzle.
Ernest Volinn, Mariko Nishikitani, Weining Volinn, Yoshio Nakamura, Eiji Yano

Spine (Phila Pa 1976)· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis